Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
DGNeurologie
Erschienen in: DGNeurologie 6/2021

07.10.2021 | Hirnblutung | Leitlinie

S2k-Leitlinie: Behandlung von spontanen intrazerebralen Blutungen

Leitlinie der Deutschen Gesellschaft für Neurologie

verfasst von: Prof. Dr. Thorsten Steiner, MME, Prof. Dr. Andreas Unterberg

Erschienen in: DGNeurologie | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Auszug

  • Bei Patienten mit akuter spontaner intrazerebraler Blutung sollte der systolische Blutdruck möglichst innerhalb von 2 h nach Beginn der Blutung auf Werte kleiner oder gleich 140 mm Hg, jedoch nicht unter 110 mm Hg gesenkt werden. Die maximale systolische Blutdrucksenkung sollte 90 mm Hg nicht überschreiten.
…
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Foerch C, Misselwitz B, Sitzer M et al (2008) Die Schlaganfallzahlen bis 2050. Dtsch Arztebl 105:467–473
2.
Sacco S, Marini C, Toni D, Olivieri L, Carolei A (2009) Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke 40:394–399PubMedCrossRef
3.
Weir CJ, Murray GD, Adams FG et al (1994) Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 344:999–1002PubMedCrossRef
4.
Al-Shahi Salman R, Frantzias J, Lee RJ et al (2018) Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data. Lancet Neurol 17:885–894PubMedPubMedCentralCrossRef
5.
Langhorne P, Fearon P, Ronning OM et al (2013) Stroke unit care benefits patients with Intracerebral hemorrhage: systematic review and meta-analysis. Stroke 44:30443049CrossRef
6.
Anderson CS, Huang Y, Wang JG et al (2008) Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 7:391–399PubMedCrossRef
7.
Anderson CS, Heeley E, Huang Y et al (2013) Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 368:2355–2365PubMedCrossRef
8.
Qureshi AI, Palesch YY, Barsan WG et al (2016) Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 375:1033–1043PubMedPubMedCentralCrossRef
9.
Boulouis G, Morotti A, Goldstein JN, Charidimou A (2017) Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. J Neurol Neurosurg Psychiatry 88:339–345PubMedCrossRef
10.
Burgess LG, Goyal N, Jones GM et al (2018) Evaluation of acute kidney injury and mortality after intensive blood pressure control in patients with Intracerebral hemorrhage. J Am Heart Assoc 7:1–11CrossRef
11.
Li Q, Warren AD, Qureshi AI et al (2020) Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol 88(2):388–395PubMedCrossRefPubMedCentral
12.
Graffagnino C, Bergese S, Love J et al (2013) Clevidipine rapidly and safely reduces blood pressure in acute Intracerebral hemorrhage: the ACCELERATE trial. Cerebrovasc Dis 36:173–180PubMedCrossRef
13.
Al-Shahi Salman R, Law ZK, Bath PM, Steiner T, Sprigg N (2018) Haemostatic therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 4(4):CD5951PubMed
14.
Imberti R, Pietrobono L, Klersy C et al (2012) Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. Minerva Anestesiol 78:168–175PubMed
15.
Wang YQ, Li X (2012) Intervention study on recombinant activated factor VIIa in depressing early hematoma extensions of cerebral hemorrhage. Chin J New Drugs 21:161–163
16.
Mayer S, Brun N, Broderick J et al (2005) Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 36:74–79PubMedCrossRef
17.
Mayer SA, Brun NC, Begtrup K et al (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358:21272137CrossRef
18.
Mayer SA, Brun NC, Broderick J et al (2006) Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial. Neurocrit Care 4:206–214PubMedCrossRef
19.
Mayer S, Brun N, Broderick J et al (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777–785PubMedCrossRef
20.
Arumugam A, Rahman NAA, Theophilus SC, Shariffudin A, Abdullah JM (2015) Tranexamic acid as antifibrinolytic agent in non traumatic intracerebral hemorrhages. Malays J Med Sci 22:62–71PubMedPubMedCentral
21.
Sprigg N, Renton CJ, Kwong Y, Dineen RA, Bath P (2012) Tranexamic acid for acute intracerebral haemorrhage (TICH): results of the first randomised controlled trial. Int J Stroke 2:7
22.
23.
Baharoglu MI, Cordonnier C, Salman RA et al (2016) Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 387:2605–2613PubMedCrossRef
24.
Boulis NM, Bobek MP, Schmaier A, Hoff JT (1999) Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 45:1113–1118 (discussion 1118–1119)PubMedCrossRef
25.
Sprigg N, Flaherty K, Appleton JP et al (2018) Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet 391:2107–2115PubMedPubMedCentralCrossRef
26.
Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J (2004) Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63:1059–1064PubMedCrossRef
27.
Steiner T, Poli S, Griebe M et al (2016) Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol 15:566–573PubMedCrossRef
28.
Pollack CV Jr., Reilly PA, Eikelboom J et al (2017) Idarucizumab for dabigatran reversal—full cohort analysis. N Engl J Med 377:431–441PubMedCrossRef
29.
Connolly SJ, Crowther M, Eikelboom JW et al (2019) Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N Engl J Med 380:1326–1335PubMedPubMedCentralCrossRef
30.
Grau A, Steiner T et al (2019) Stellungnahme der DSG zum Einsatz von Andexanet Alpha. DSG,
31.
EMA (2019) Ondexxya Anhang I: Zusammenfassung der Merkmale des Arzneimittels
32.
Zahir H, Brown KS, Vandell AG et al (2015) Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate. Circulation 131:82–90PubMedCrossRef
33.
Prasad K, Mendelow AD, Gregson B (2008) Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev 4:CD200
34.
Mendelow AD, Gregson B (2011) Surgery for intracerebral haemorrhage. In: Mohr JP (Hrsg) Stroke—pathophysiology, diagnosis, and management with expert consult. Elsevier Saunders, Philadelphia
35.
Mendelow AD, Gregson BA, Fernandes HM et al (2005) Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 9457:387–397CrossRef
36.
Mendelow AD, Gregson BA, Rowan EN et al (2013) Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trial. Lancet 382:397–408PubMedPubMedCentralCrossRef
37.
38.
Sondag L, Schreuder F, Boogaarts HD et al (2020) Neurosurgical intervention for supratentorial intracerebral hemorrhage. Ann Neurol 88(2):239–250PubMedPubMedCentralCrossRef
39.
Hanley DF, Thompson RE, Muschelli J, et al (2016) Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol 15:1228–1237PubMedPubMedCentralCrossRef
40.
Hanley DF, Thompson RE, Rosenblum M, et al (2019) Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet 393:1021–1032PubMedPubMedCentralCrossRef
41.
Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1999) Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617–621PubMedCrossRef
42.
Hanley DF, Lane K, McBee N et al (2017) Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet 389:603–611PubMedPubMedCentralCrossRef
43.
Staykov D, Kuramatsu JB, Bardutzky J et al (2016) Efficacy and safety of combined intraventricular fibrinolysis with lumbar drainage for prevention of permanent shunt dependency after intracerebral hemorrhage with severe ventricular involvement: A randomized trial and individual patient data meta-analysis. Ann Neurol 81:93–103CrossRef
44.
Mokri B (2001) The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology 56:1746–1748PubMedCrossRef
45.
Bullock R, Golek J, Blake G (1989) Traumatic intracerebral hematoma—which patients should undergo surgical evacuation? CT scan features and ICP monitoring as a basis for decision making. Surg Neurol 32:181–187PubMedCrossRef
46.
Constantini S, Cotev S, Rappaport ZH et al (1988) Intracranial pressure monitoring after elective intracranial surgery. A retrospective study of 514 patients. J Neurosurg 69:540–544PubMedCrossRef
47.
Hawryluk GWJ, Nielson JL, Huie JR et al (2020) Analysis of normal high-frequency intracranial pressure values and treatment threshold in neurocritical care patients: insights into normal values and a potential treatment threshold. JAMA Neurol 77(9):11501158CrossRef
48.
Ziai WC, Thompson CB, Mayo S et al (2019) Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage: occurrence and associations with outcome. Crit Care Med 47:1125–1134PubMedPubMedCentralCrossRef
49.
Che XR, Wang YJ, Zheng HY (2020) Prognostic value of intracranial pressure monitoring for the management of hypertensive intracerebral hemorrhage following minimally invasive surgery. World J Emerg Med 11:169–173PubMedPubMedCentralCrossRef
50.
51.
Kuramatsu JB, Biffi A, Gerner ST et al (2019) Association of surgical hematoma evacuation vs conservative treatment with functional outcome in patients with cerebellar Intracerebral hemorrhage. JAMA 322:1392–1403PubMedPubMedCentralCrossRef
52.
Kuramatsu JB, Gerner ST, Schellinger PD et al (2015) Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313:824–836PubMedCrossRef
53.
Kuramatsu JB, Sembill JA, Gerner ST et al (2018) Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves. Eur Heart J 39:1709–1723PubMedPubMedCentralCrossRef
54.
Gerner ST, Kuramatsu JB, Sembill JA et al (2018) Association of prothrombin complex concentrates administration and hematoma enlargement in NOAC-related intracerebral hemorrhage. Ann Neurol 83:186–196PubMedCrossRef
55.
Sprugel MI, Kuramatsu JB, Gerner ST et al (2018) Antiplatelet therapy in primary spontaneous and oral anticoagulation-associated intracerebral hemorrhage. Stroke 49:2621–2629PubMedCrossRef
56.
Woo D, Rosand J, Kidwell C et al (2013) The ethnic/racial variations of intracerebral hemorrhage (ERICH) study protocol. Stroke 44:e120–125PubMedCrossRef
57.
Chen R, Wang X, Anderson CS et al (2019) Infratentorial intracerebral hemorrhage. Stroke 50:1257–1259PubMedCrossRef
58.
Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC (2008) Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 39:3029–3035PubMedCrossRef
59.
den Hertog HM, van der Worp HB, van Gemert HM et al (2009) The paracetamol (acetaminophen) in stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 8:434–440CrossRef
60.
61.
Broessner G, Beer R, Lackner P et al (2009) Prophylactic, endovascularly based, long-term normothermia in ICU patients with severe cerebrovascular disease: bicenter prospective, randomized trial. Stroke 40:e657–665PubMedCrossRef
62.
Kollmar R, Schellinger P, Schwab S (2008) Hypothermia and decompression after intracerebral hemorrhage (HyDe-H). 17th European Stroke Conference (ESC), Nizza
63.
Zhang XM, Li XL, Tang SH, Liu QC (2006) Effect of head hypothermia on serum inflammatory cytokines levels in patients with hypertensive intracerebral hemorrhage. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 18:294–296PubMed
64.
Dohi K, Jimbo H, Ikeda Y et al (2006) Pharmacological brain cooling with indomethacin in acute hemorrhagic stroke: antiinflammatory cytokines and antioxidative effects. Acta Neurochir Suppl 96:57–60PubMedCrossRef
65.
Su Z‑Q, Wang Y, Zhao Q‑J et al (2004) Recent effect of local mild hypothermia for improving neurological deficits in patients with cerebral hemorrhage. Chin J Clin Rehabil 8:1816–1817
66.
Fu X‑H, Sun J, Li H‑P (2005) Functional prognosis affected by temperature control treatment in the near future in patients with stroke. Zhongguo Li Chuan Kung Fu 9:4–5
67.
Diringer MN (2004) Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med 32:559–564PubMedCrossRef
68.
Huang H, Liu F, Zhan R (2003) Treatment of hypertensive cerebral hemorrhage by early-used mild hypothermia. Zhejiang Med J 25:326–327
69.
Kollmar R, Staykov D, Dorfler A et al (2010) Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke 41:1684–1689PubMedCrossRef
70.
Feng H, Shi D, Wang D et al (2002) Effect of local mild hypothermia on treatment of acute intracerebral hemorrhage, a clinical study. Zhonghua Yi Xue Za Zhi 82:1622–1624PubMed
71.
Xu L, Li X, Zhang X (2002) Clinical efficacy of head mild hypothermia in treatment of hypertensive intracerebral haemorrhage. Chin J Geriatr Cardiovasc Cerebrovasc Dis 4:327–329
72.
Kallmunzer B, Krause C, Pauli E et al (2011) Standardized antipyretic treatment in stroke: a pilot study. Cerebrovasc Dis 31:382–389PubMedCrossRef
73.
Penner M, Silasi G, Wowk S, Warkentin L, Colbourne F (2011) Brief hyperthermia does not worsen outcome after striatal hemorrhage in rats. Curr Neurovasc Res 8:35–43PubMedCrossRef
74.
Abdullah JM, Husin A (2011) Intravascular hypothermia for acute hemorrhagic stroke: a pilot study. Acta Neurochir Suppl 111:421–424PubMedCrossRef
75.
Lacut K, Bressollette L, Le Gal G et al (2005) Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology 65:865–869PubMedCrossRef
76.
Orken DN, Kenangil G, Ozkurt H et al (2009) Prevention of deep venous thrombosis and pulmonary embolism in patients with acute intracerebral hemorrhage. Neurologist 15:329–331PubMedCrossRef
77.
Paciaroni M, Agnelli G, Venti M et al (2011) Efficacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage: a meta-analysis of controlled studies. J Thromb Haemost 9:893–898PubMedCrossRef
78.
Dennis M, Sandercock PA, Reid J et al (2009) Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet 373:1958–1965PubMedCrossRef
79.
Boeer A, Voth E, Henze T, Prange HW (1991) Early heparin therapy in patients with spontaneous intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 54:466–467PubMedPubMedCentralCrossRef
80.
Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G (2002) Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 43:1175–1180PubMedCrossRef
81.
Alberti A, Paciaroni M, Caso V et al (2008) Early seizures in patients with acute stroke: frequency, predictive factors, and effect on clinical outcome. Vasc Health Risk Manag 4:715–720PubMedPubMedCentralCrossRef
82.
Bladin CF, Alexandrov AV, Bellavance A et al (2000) Seizures after stroke: a prospective multicenter study. Arch Neurol 57:1617–1622PubMedCrossRef
83.
Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E (1997) Predictive factors of early seizures after acute cerebrovascular disease. Stroke 28:1590–1594PubMedCrossRef
84.
Giroud M, Gras P, Fayolle H et al (1994) Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 35:959–964PubMedCrossRef
85.
Burneo JG, Fang J, Saposnik G (2010) Impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study. Eur J Neurol 17:52–58PubMedCrossRef
86.
Garrett MC, Komotar RJ, Starke RM et al (2009) Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy. J Crit Care 24:335–339PubMedCrossRef
87.
Desai P, Prasad K (1998) Dexamethasone is not necessarily unsafe in primary supratentorial intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 65:799–800PubMedPubMedCentralCrossRef
88.
Hooshmand H, Quinn JC, Houff SA (1972) Cerebrospinal fluid pressure changes with chemotherapy for intracerebral hemorrhage. Neurology 22:56–61PubMedCrossRef
89.
Ogun SA, Odusote KA (2001) Effectiveness of high dose dexamethasone in the treatment of acute stroke. West Afr J Med 20:1–6PubMed
90.
Poungvarin N, Bhoopat W, Viriyavejakul A et al (1987) Effects of dexamethasone in primary supratentorial intracerebral hemorrhage. N Engl J Med 316:1229–1233PubMedCrossRef
91.
Tellez H, Bauer RB (1973) Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 4:541–546PubMedCrossRef
92.
Feigin VL, Anderson NE, Rinkel GJE et al (2005) Corticosteroids for aneurysmal subarachnoid hemorrhage and primary intracerebral hemorrhage. Cochrane Database Syst Rev 3:CD4583
93.
Sharafadinzadeh N, Baghebanian SM, Pipelzadeh M, Maravej AAA, Ghanavati P (2008) Effects of dexamethasone in primary intracerebral hemorrhage in the south west of Iran. Pak J Med Sci 24:502–505
94.
Hemphill JC 3rd, Farrant M, Neill TA Jr. (2009) Prospective validation of the ICH Score for 12-month functional outcome. Neurology 73:1088–1094PubMedPubMedCentralCrossRef
95.
Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897PubMedCrossRef
96.
Naidech AM, Bernstein RA, Bassin SL et al (2009) How patients die after intracerebral hemorrhage. Neurocrit Care 11:45–49PubMedCrossRef
97.
Hemphill JC 3rd, Newman J, Zhao S, Johnston SC (2004) Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 35:1130–1134PubMedCrossRef
98.
Becker KJ, Baxter AB, Cohen WA et al (2001) Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 56:766–772PubMedCrossRef
99.
Creutzfeldt CJ, Becker KJ, Weinstein JR et al (2011) Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med 39:158–162PubMedPubMedCentralCrossRef
100.
101.
Carrese JA, Sugarman J (2006) The inescapable relevance of bioethics for the practicing clinician. Chest 130:1864–1872PubMedCrossRef
102.
Rydvall A, Lynoe N (2008) Withholding and withdrawing life-sustaining treatment: a comparative study of the ethical reasoning of physicians and the general public. Crit Care 12:R13PubMedPubMedCentralCrossRef
103.
Broderick J, Brott T, Duldner JE, Tomsick T, Huster G (1993) Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 24:987–993PubMedCrossRef
104.
Diringer MN, Edwards DF, Zazulia AR (1998) Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 29:1352–1357PubMedCrossRef
105.
Zahuranec DB, Brown DL, Lisabeth LD et al (2007) Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 68:1651–1657PubMedCrossRef
106.
Bardach N, Zhao S, Pantilat S, Johnston SC (2005) Adjustment for do-not-resuscitate orders reverses the apparent in-hospital mortality advantage for minorities. Am J Med 118:400–408PubMedCrossRef
107.
Zahuranec DB, Brown DL, Lisabeth LD et al (2009) Ethnic differences in do-not-resuscitate orders after intracerebral hemorrhage. Crit Care Med 37:2807–2811PubMedPubMedCentralCrossRef
108.
PROGRESS Collaborative Group. (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033–1041CrossRef
109.
Arima H, Tzourio C, Anderson C et al (2010) Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke 41:394–396PubMedCrossRef
110.
Kizer JR, Dahlof B, Kjeldsen SE et al (2005) Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the losartan intervention for endpoint reduction in hypertension study. Hypertension 45:46–52PubMedCrossRef
111.
Perry HM Jr., Davis BR, Price TR et al (2000) Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the systolic hypertension in the elderly program (SHEP). JAMA 284:465–471PubMedCrossRef
112.
Jamerson K, Weber MA, Bakris GL et al (2008) Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359:2417–2428PubMedCrossRef
113.
Dahlof B, Sever PS, Poulter NR et al (2005) Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian cardiac outcomes trial-blood pressure lowering arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 366:895–906PubMedCrossRef
114.
Arguedas JA, Perez MI, Wright JM (2009) Treatment blood pressure targets for hypertension. Cochrane Database Syst Rev 3:CD4349
115.
Shoamanesh A (2020) NOACs for stroke prevention in patients with atrial fibrillation and previous ICH (NASPAF-ICH)
116.
Koen M et al (2015) Apixaban versus antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated Intracerebral haemorrhage in patients with atrial fibrillation (APACHE-AF)
117.
118.
119.
120.
121.
122.
123.
Biffi A, Kuramatsu JB, Leasure A et al (2017) Oral anticoagulation and functional outcome after intracerebral hemorrhage. Ann Neurol 82:755–765PubMedPubMedCentralCrossRef
124.
Murthy SB, Gupta A, Merkler AE et al (2017) Restarting anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis. Stroke 48:1594–1600PubMedPubMedCentralCrossRef
125.
Pennlert J, Overholser R, Asplund K et al (2017) Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke 48:314–320PubMedCrossRef
126.
Wilson D, Ambler G, Shakeshaft C et al (2018) Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study. Lancet Neurol 17:539–547PubMedPubMedCentralCrossRef
127.
Sahay S, Nombela-Franco L, Rodes-Cabau J et al (2017) Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials. Heart 103:139–147PubMedCrossRef
128.
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al (2017) 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol 70:2964–2975PubMedCrossRef
Metadaten
Titel
S2k-Leitlinie: Behandlung von spontanen intrazerebralen Blutungen
Leitlinie der Deutschen Gesellschaft für Neurologie
verfasst von
Prof. Dr. Thorsten Steiner, MME
Prof. Dr. Andreas Unterberg
Publikationsdatum
07.10.2021
Verlag
Springer Medizin
Erschienen in
DGNeurologie / Ausgabe 6/2021
Print ISSN: 2524-3446
Elektronische ISSN: 2524-3454
DOI
https://doi.org/10.1007/s42451-021-00381-z

Weitere Artikel der Ausgabe 6/2021

DGNeurologie 6/2021 Zur Ausgabe

Leserbriefe

S2k-Leitlinie multiplen Sklerose der DGN - zwischen Kritik und Rechtfertigung

Scientific News

Neue Studie zur Klassifikation der Multiplen Sklerose mithilfe künstlicher Intelligenz

Leserbriefe

NeurologyFirst unterstützt die neue MS-Leitlinie der DGN

SOP/Algorithmus

Diagnostik beim Fallfuß

Magazin

Magazin

Neuro-Quiz

74-jähriger Patient mit akuter Monoparese des rechten Beins

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 | Parkinson-Krankheit | Podcast | Nachrichten

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus
Professorin Dr. Claudia Trenkwalder, Neurologin

22.04.2024 | DGIM 2024 | Nachrichten

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

19.04.2024 | AAN-Jahrestagung 2024 | Nachrichten

Hustenstiller lindert Agitation bei Alzheimer
weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise